NM_001110354.2(ZP3):c.1113G>T (p.Arg371Ser) AND not provided

This record was updated by the submitter. Please see the current version.

Germline classification:: Benign (2 submissions)
Last evaluated:: Jun 1, 2024
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000884653.13

Allele description

NM_001110354.2(ZP3):c.1113G>T (p.Arg371Ser)

Gene:

ZP3:zona pellucida glycoprotein 3 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7q11.23

Genomic location:

Preferred name:

NM_001110354.2(ZP3):c.1113G>T (p.Arg371Ser)

HGVS:

NC_000007.14:g.76441894G>T
NG_033938.1:g.49371G>T
NM_001110354.2:c.1113G>TMANE SELECT
NM_007155.6:c.960G>T
NP_001103824.1:p.Arg371Ser
NP_009086.4:p.Arg320Ser
NC_000007.13:g.76071211G>T
NM_001110354.1:c.1113G>T

Protein change:

R320S

Links:

dbSNP: rs200481427

NCBI 1000 Genomes Browser:

rs200481427

Molecular consequence:

NM_001110354.2:c.1113G>T - missense variant - [Sequence Ontology: SO:0001583]
NM_007155.6:c.960G>T - missense variant - [Sequence Ontology: SO:0001583]

Observations:

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Williams-Beuren syndrome critical region protein 19 [Homo sapiens]
Williams-Beuren syndrome critical region protein 19 [Homo sapiens]
gi|21552752|gb|AAM62309.1|AF412027_

Protein
hypothetical protein PADG_05347 [Paracoccidioides brasiliensis Pb18]
hypothetical protein PADG_05347 [Paracoccidioides brasiliensis Pb18]
gi|226293848|gnl|WGS:ABKI|PADG_0534 EEH49268.1|

Protein
Microbe sample from Rhizobium changzhiense sp.
Microbe sample from Rhizobium changzhiense sp.

biosample
DUF927 domain-containing protein, partial [Methylohalobius crimeensis]
DUF927 domain-containing protein, partial [Methylohalobius crimeensis]
gi|551330775|ref|WP_022950216.1|

Protein
CGH_1_HP_G0069470.mRNA.1.CDS.1 [Saccharomyces cerevisiae]
CGH_1_HP_G0069470.mRNA.1.CDS.1 [Saccharomyces cerevisiae]
gi|2368741686|emb|CAI4994340.1||gnl CANB|CAI4994340

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001028048	Invitae	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Benign (Dec 31, 2019)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV004032743	CeGaT Center for Human Genetics Tuebingen	criteria provided, single submitter (CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)	Benign (Jun 1, 2024)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001028048

Invitae

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Benign
(Dec 31, 2019)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004032743

CeGaT Center for Human Genetics Tuebingen

criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)

Benign
(Jun 1, 2024)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	yes	3	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Invitae, SCV001028048.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From CeGaT Center for Human Genetics Tuebingen, SCV004032743.9

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	3	not provided	not provided	clinical testing	not provided

Description

ZP3: PP2, BP4, BS1, BS2

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		3	not provided	not provided	not provided

Last Updated: Aug 4, 2024

ClinVar

Relating variation to medicine